LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Neutral With $125 Price Target 11/25/2015 6:41:37 AM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q4 16 Estimate To -0.56 From -0.44 11/20/2015 12:52:46 PM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q3 16 Estimate To -0.64 From -0.53 11/20/2015 12:52:25 PM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q2 16 Estimate To -0.55 From -0.46 11/20/2015 12:52:01 PM
  • Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q1 16 Estimate To -0.83 From -0.80 11/20/2015 12:51:41 PM
  • Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) FY16 Estimate To -2.57 From -2.23 11/20/2015 12:51:24 PM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY16 Rev. Estimate To 1.16 Billion From 1.22 Billion 11/20/2015 12:50:36 PM
  • Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q4 16 Rev. Estimate To 310.7 M From 331.2 M 11/20/2015 12:50:10 PM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q3 16 Rev. Estimate To 294.6 M From 311.6 M 11/20/2015 12:49:41 PM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q2 16 Rev. Estimate To 308.5 M From 322.1 M 11/20/2015 12:49:16 PM
  • Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q1 16 Rev. Estimate To 250.1 M From 254.1 M 11/20/2015 12:48:45 PM
  • Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Neutral With $125 Down From $137 Price Target 11/20/2015 12:28:47 PM
  • RBC Capital Markets Is Increasing Biomarin Pharmaceutical Inc. (BMRN) 4Q15 Rev. Estimate To 225.2 M From 214.9 M 10/30/2015 1:38:16 PM
  • RBC Capital Markets Is Lowering Biomarin Pharmaceutical Inc. (BMRN) FY17 Rev. Estimate To 1.343 Billion From 1.380 Billion 10/30/2015 1:37:47 PM
  • RBC Capital Markets Is Lowering Biomarin Pharmaceutical Inc. (BMRN) FY16 Rev. Estimate To 1.113 Billion From 1.125 Billion 10/30/2015 1:36:56 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap